Building a market access blueprint for lung cancer diagnostics in Asia-Pacific Lung cancer is the leading cause of cancer mortality in the… Cancer diagnostics | Centralised Diagnostics (CEDx) | In-vitro diagnostics | Molecular Diagnostics (MDx) | Asia | Global | Centralised Diagnostics (CEDx) | IVD Gateway | Molecular Diagnostics (MDx)
Launching a new value proposition for core lab solutions An IVD multinational company is preparing to roll out a new… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Americas | Asia | Europe | Global | Middle East & Africa | Centralised Diagnostics (CEDx) | IVD Gateway
Uncovering opportunities faster with IVD Size & Share Plus In dynamic market segments such as infectious disease… In-vitro diagnostics | Global | IVD Gateway | Size and Share Plus
Support strategic market planning with IVD Size & Share Plus Enable winning go-to-market strategies by tracking… In-vitro diagnostics | Uncategorised | Global | IVD Gateway | Size and Share Plus
Drive decision-making with IVD Size & Share Plus One of the largest IVD multinational companies plans to… In-vitro diagnostics | Global | Centralised Diagnostics (CEDx) | IVD Gateway | Size and Share Plus
Supporting the global launch of a clinical chemistry assay One of the largest IVD multinational companies plans to… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Global | Centralised Diagnostics (CEDx) | IVD Gateway
Clearstate newsletterSign up to our newsletter for insights into key market data, trends and developments across IVD and Surgical segments from our specialists and analysts. Sign up now